failed_experiment.db
← Back to browse

Biochemistry, Genetics and Molecular Biology› Molecular Biology› Muscle Physiology and Disorders

Exercise physiology and geroscience — Metformin as an adjunct to progressive resistance training

Submitted 2026-10-22

Field: Biochemistry, Genetics and Molecular Biology › Molecular BiologyType: An approach that didn't workArea: exercise physiology and geroscienceTarget: Metformin as an adjunct to progressive resistance trainingStage: randomized trial

Hypothesis

Because metformin dampens inflammation, adding it to 14 weeks of supervised resistance training would augment the muscle response in healthy adults aged 65 and over.

What failed

Among 94 randomized participants the placebo group gained more lean body mass (p = .003) and thigh muscle mass (p < .001), and more thigh muscle area (p = .005) and density (p = .020), than the metformin group, with strength gains trending lower on metformin; fibre hypertrophy and satellite-cell and macrophage abundance were unaffected.

Broken assumption

Suppressing training-related inflammation helps rather than hinders muscle hypertrophy.

Why

The authors report that metformin raised AMPK signalling and tended to blunt the training-induced rise in mTORC1 signalling, and that placebo but not metformin lowered the type I fibre percentage.

From the published paper: Walton et al. Aging Cell, 2019. ↗CC BY

Research ideas from this failure

Unvetted lead — read the papers

New hypotheses this failure suggests, each with a crucial experiment, a rival explanation of the original result, and the papers it rests on. Written by AI from paper titles and abstracts found on OpenAlex (and Europe PMC, for life and health sciences).

Related failures

Nothing else logged looks close to this one yet.

Links in published research

Where this experiment's genes are known to matter outside its own research area, and the papers behind those links. Sources: Open Targets Platform and Europe PMC.